Loading ...

doxorubicin-loaded epidermal growth factor expressing bacterial protoplast-derived nanovesicles

Based on

1 Articles
2017 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

PrsA-EGF fusion protein expressing Escherichia coli protoplast

PrsA-EGF expressing Escherichia coli protoplast PrsA-EGF expressing E. coli protoplast
Type Bioobject
Formula
Role carriers
2

doxorubicin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
human lung carcinoma A459 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • PrsA-EGF fusion protein expressing Escherichia coli
  1. DKhLeEa7
  2. 3TBCE
Product

doxorubicin-loaded epidermal growth factor expressing bacterial protoplast-derived nanovesicles

Hydrodynamic diameter: ~ 80 nm

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • Escherichia coli
  1. HGPlwcz7
  2. yMg6B
Product

doxorubicin-loaded epidermal growth factor expressing bacterial protoplast-derived nanovesicles

Hydrodynamic diameter: ~ 80 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial